121 related articles for article (PubMed ID: 36690533)
1. Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma.
Li M; Wu L; Luo S; Liu Y; Sun C; Li E; Wang J; Li B; Huang Z; Ge J; Lei J; Zhou F; Liao W
Eur J Surg Oncol; 2023 Jul; 49(7):1217-1225. PubMed ID: 36690533
[TBL] [Abstract][Full Text] [Related]
2. [Validation and modification of AJCC 8th edition staging system for hepatocellular carcinoma--analysis based on SEER database].
Wei YZ; Huang YQ; Zeng SY; Cai ZB; Peng YH; Zhu CL; Yu WL; Zhou YM
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2216-2222. PubMed ID: 34333934
[No Abstract] [Full Text] [Related]
3. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival between adolescent and young adult
Ren J; Tong YM; Cui RX; Wang Z; Li QL; Liu W; Qu K; Zhang JY; Liu C; Wan Y
World J Gastrointest Oncol; 2020 Dec; 12(12):1394-1406. PubMed ID: 33362910
[TBL] [Abstract][Full Text] [Related]
6. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study.
Luo S; Wu L; Li M; Wang J; Wang C; Yang J; Zhang L; Ge J; Sun C; Li E; Lei J; Zhou F; Liao W
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675604
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
9. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
[TBL] [Abstract][Full Text] [Related]
10. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
[TBL] [Abstract][Full Text] [Related]
11. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
12. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
Liu X; Gao H; Zhang J; Xue D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
[TBL] [Abstract][Full Text] [Related]
13. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
[TBL] [Abstract][Full Text] [Related]
14. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.
Lin Q; Huang X; Zhong C; Luo T; Zeng X; Chen S
Cancer Med; 2019 Feb; 8(2):515-526. PubMed ID: 30656831
[TBL] [Abstract][Full Text] [Related]
15. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
16. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
17. The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis.
Giannis D; Morsy S; Geropoulos G; Esagian SM; Sioutas GS; Moris D
In Vivo; 2021; 35(1):393-399. PubMed ID: 33402488
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
Lin H; Li X; Liu Y; Hu Y
ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
Qiu S; Chen R; Hu J; Han T
Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study.
Kokabi N; Xing M; Duszak R; Duszak R; Howard DH; Applegate KE; Camacho JC; Kim HS
Future Oncol; 2016 Jan; 12(2):183-98. PubMed ID: 26690268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]